A very pertinent question, especially as the pendulum has swung towards treating esophageal cancers with neoadjuvant therapy - indeed, it has been quite a few years since I have treated an esophageal cancer case adjuvantly. The way I think about it, is that what is good for neoad...

While in the US/ Europe, the overwhelming approach for ESCC is neoadjuvant chemoradiation +/- surgery (our institution uses surgery only for incomplete response to chemoradiation based on the German/French data), in Asian countries, where the relative percent of squamous cell carcinomas is higher th...